IRIS and AEYE Health partner to bring AI technology integrations to more providers and simplify diabetic retinopathy screenings

AEYE Health Welcomes Renowned Physician Guillermo Umpierrez, MD, CDCES as New Medical Board Advisor, and Prepares for Engaging Exhibitions at ENDO 2023 and ADA's 83rd Scientific Sessions

AEYE Health receives FDA 510(k) for AI-backed diabetic retinopathy screening

Eye AI? Aye-aye, FDA tells AEYE

AEYE Health gains FDA clearance to screen diabetics to head off blindness

FDA Green Lights AEYE Health’s AI-Based Autonomous Screening for Referable Diabetic Retinopathy

AEYE Health gets FDA approval to screen diabetics to prevent blindness

AEYE Health reports results of its AI algorithm for autonomous screening and detection of diabetic retinopathy

IRIS and AEYE Health Announce Partnership to Provide AI Screening to Market

What Drives Israel At 75? ‘Everything Is Possible’

AI Screening System For Blindness Associated With Diabetes Gets FDA Nod

Aeye eyes ‘aye’ from FDA for AI tool to prevent diabetes-related blindness

AEYE Health receives FDA clearance for AI-based autonomous screening for referable diabetic retinopathy

AEYE Health gets FDA approval to screen diabetics to prevent blindness

מונעת עיוורון: Aeye Health פיתחה תוכנת AI לאבחון סוכרת דרך הרשתית

UMass Medical School and AEYE Health Leverage Artificial Intelligence to Help Family Physicians Assess and Refer patients with Eye Conditions to Specialists

The Bethesda Health Clinic implements AEYE Health's AI-based Screening Technology to Provide the Working But Uninsured East Texans with Free Diabetic Retinopathy Screenings

AI Takes Root in Primary Care. First Stop: Diabetic Retinopathy

AEYE Health wins FDA clearance for AI-powered eye test to expand diabetic screening

AEYE Health Gets FDA Approval to Screen Diabetics to Prevent Blindness

AI For Diabetic Retinopathy Screening Gets U.S. FDA Approval

AEYE Health gets FDA clearance to use AI to screen diabetics in hopes of preventing blindness

AEYE Health Reports Pivotal Clinical Trial Results of its AI Algorithm for the Autonomous Screening and Detection of More-Than-Mild Diabetic Retinopathy